Breast Cancer Patients, Prostate Cancer Patients
Conditions
Keywords
cancer survivors, breast cancer, prostate cancer, neo-/adjuvant chemotherapy, quality of life
Brief summary
The questionnaire for assessment of adverse events after completion of cancer treatment, which is being piloted at the Masaryk Memorial Cancer Institute, aims to detect a wide range of adverse effects early on, thus facilitating adequate intervention and planning of follow-up care for all cancer survivors.
Detailed description
According to the current recommendations of the European Society for Medical Oncology (ESMO), comprehensive care for cancer survivors should focus on five main areas: 1) the physical effects of the disease and subsequent treatment, 2) the psychological effects of the disease and treatment, 3) the social, occupational, and financial impacts of the disease and treatment, 4) early detection of recurrence or subsequent primary malignancies, and last but not least, 5) prevention of cancer and promotion of healthy lifestyles. The proposed questionnaire should effectively and comprehensively reflect both the physical problems typically associated with a given diagnosis and the psychological, social, occupational, and financial impacts. It should also focus the physician's attention on interventions aimed at healthy lifestyles (smoking cessation, obesity prevention, sufficient physical activity) to maintain the health of cancer survivors.
Interventions
OTHERactive screening of adverse effects of anticancer therapy based on specific questionnaire + quality of life screening
Based on the Questionnaire for the Assessment of Difficulties after the completion of cancer treatment, the attending physician will assess the need for intervention and respond appropriately to the reported problems. Intervention is assessed as education by the physician, the use of medication, or referral of the patient to a specialized outpatient clinic.
Sponsors
Masaryk Memorial Cancer Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* The patient understands the information provided and agrees to participate in the study. * Age 18 years or older. * Histologically confirmed invasive breast cancer or invasive prostate cancer. * Completion of the acute phase of curative oncological therapy: * for breast cancer: curative surgery performed + completed neoadjuvant/adjuvant chemotherapy and completed adjuvant radiotherapy, if indicated * for prostate cancer: completed radiotherapy with curative intent or radical prostatectomy performed (open, laparoscopic, robotic) or completed adjuvant radiotherapy after prostatectomy * The patient is available for follow-up within 12 months of enrollment in the study.
Exclusion criteria
* Active ongoing oncological therapy (except for (i) adjuvant hormone therapy, (ii) adjuvant targeted therapy (anti-HER2 therapy, CDK4/6i, PARPi, T-DM1), (iii) adjuvant immunotherapy) * Neoadjuvant/adjuvant therapy did not include chemotherapy (breast cancer). * Recurrence of cancer * Metastatic disease * History of other primary malignancy (except for non-melanoma skin cancer)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Impact of active monitoring of adverse effects on quality of life | Upon enrollment (baseline), six and twelve months after baseline | Compare the quality of life of breast and prostate cancer survivors between the interventional group, in which adverse effects are actively monitored using the Questionnaire for the Assessment of Difficulties after Cancer Treatment, and the control group. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comprehensibility of the questionnaire | Upon enrollment (baseline), six and twelve months after baseline | Evaluation of the comprehensibility of the Questionnaire for the Assessment of Difficulties after Cancer Treatment. |
| Usability of the questionnaire in routine clinical practice | Upon enrollment (baseline), six and twelve months after baseline | Evaluation of the usability of the Questionnaire for the Assessment of Difficulties in routine clinical practice. |
| Frequency of active intervention by a physician | Upon enrollment (baseline), six and twelve months after baseline | Assessment of the impact of active monitoring of adverse effects, based on the Questionnaire for the Assessment of Difficulties after Cancer Treatment, on the frequency of active physician interventions in the interventional group. |
Countries
Czechia
Contacts
CONTACTLenka Pavčíková, MUDr.
CONTACTMartina Lojová, Ph.D.
Outcome results
None listed